Name
rrtslope
Label
Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Description
PVT QC Rules 3-25-09 FINAL
Type
numeric
Visit (Number) vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,199 | -2.2 | ± 44.4 | -0.02 | -888.0 | 0.2 | 317 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 877 | -1.0 | ± 30.0 | -0.02 | -888.0 | 0.1 | 639 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 848 | -1.1 | ± 30.5 | -0.02 | -888.0 | 0.1 | 668 | 1,516 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | -2.2 | ± 44.4 | -0.02 | -888.0 | 0.2 | 317 | 1,516 |
Male | 767 | -2.3 | ± 45.3 | -0.02 | -888.0 | 0.1 | 191 | 958 |
Female | 432 | -2.1 | ± 42.7 | -0.02 | -888.0 | 0.2 | 126 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | -1.0 | ± 30.0 | -0.02 | -888.0 | 0.1 | 639 | 1,516 |
Male | 569 | -0.03 | ± 0.04 | -0.02 | -0.2 | 0.1 | 389 | 958 |
Female | 308 | -2.9 | ± 50.6 | -0.02 | -888.0 | 0.09 | 250 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | -1.1 | ± 30.5 | -0.02 | -888.0 | 0.1 | 668 | 1,516 |
Male | 550 | -0.03 | ± 0.04 | -0.02 | -0.2 | 0.1 | 408 | 958 |
Female | 298 | -3.0 | ± 51.4 | -0.03 | -888.0 | 0.09 | 260 | 558 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | -2.2 | ± 44.4 | -0.02 | -888.0 | 0.2 | 317 | 1,516 |
Native American | 20 | -0.02 | ± 0.04 | -0.01 | -0.09 | 0.07 | 8 | 28 |
Asian | 71 | -0.03 | ± 0.04 | -0.03 | -0.1 | 0.09 | 18 | 89 |
Black | 115 | -0.03 | ± 0.05 | -0.02 | -0.2 | 0.1 | 57 | 172 |
Hispanic | 83 | -0.03 | ± 0.05 | -0.02 | -0.2 | 0.1 | 33 | 116 |
White | 902 | -3.0 | ± 51.2 | -0.02 | -888.0 | 0.2 | 200 | 1,102 |
Other | 8 | -0.02 | ± 0.04 | -0.008 | -0.09 | 0.02 | 1 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | -1.0 | ± 30.0 | -0.02 | -888.0 | 0.1 | 639 | 1,516 |
Native American | 13 | -0.05 | ± 0.04 | -0.05 | -0.1 | 0.03 | 15 | 28 |
Asian | 48 | -0.03 | ± 0.05 | -0.02 | -0.2 | 0.06 | 41 | 89 |
Black | 76 | -11.7 | ± 101.9 | -0.03 | -888.0 | 0.1 | 96 | 172 |
Hispanic | 65 | -0.03 | ± 0.05 | -0.02 | -0.2 | 0.1 | 51 | 116 |
White | 672 | -0.03 | ± 0.04 | -0.02 | -0.2 | 0.1 | 430 | 1,102 |
Other | 3 | -0.03 | ± 0.04 | -0.05 | -0.06 | 0.006 | 6 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | -1.1 | ± 30.5 | -0.02 | -888.0 | 0.1 | 668 | 1,516 |
Native American | 13 | -0.05 | ± 0.05 | -0.03 | -0.1 | 0.01 | 15 | 28 |
Asian | 50 | -0.05 | ± 0.04 | -0.05 | -0.1 | 0.03 | 39 | 89 |
Black | 75 | -0.04 | ± 0.05 | -0.03 | -0.2 | 0.07 | 97 | 172 |
Hispanic | 61 | -0.04 | ± 0.05 | -0.03 | -0.3 | 0.05 | 55 | 116 |
White | 646 | -1.4 | ± 34.9 | -0.02 | -888.0 | 0.1 | 456 | 1,102 |
Other | 3 | 0.02 | ± 0.05 | 0.01 | -0.03 | 0.07 | 6 | 9 |